CAPR CAPRICOR THERAPEUTICS, INC. Insider Trading

EVP General Counsel sells ~45% of holdings while simultaneously purchasing shares; net exit amid stock recovery from lows.

Krasney Karen, the company's EVP and General Counsel, executed a paired transaction—buying and selling shares on the same day—that reveals a nuanced insider posture. She purchased a meaningful stake while simultaneously liquidating roughly half her total holdings, suggesting neither bullish conviction nor bearish panic, but rather portfolio rebalancing or tax-motivated trading. What's notable is the timing: the stock has recovered significantly from its lows and is trading below its year-to-date highs, yet this C-suite officer is trimming exposure rather than adding. Against the company's challenging fundamentals—operating at a substantial net loss with no current annual revenue—this selective exit from a senior executive raises a yellow flag about near-term confidence. The transaction itself is material enough to trigger SEC thresholds, but the paired buy-sell structure muddles the interpretive signal that a straightforward sale would convey.

CFO Bergmann executes same-day option exercise and full sale, harvesting gains while company burns cash with no revenue.

CFO Anthony Bergmann exercised options and immediately sold the entire position on the same day, converting an acquisition valued at roughly $80,000 into proceeds of approximately $793,000. This is Bergmann's second open-market sale at Capricor in six months, following a prior exit in late March where the stock subsequently rose—indicating poor timing on his previous exit. The current sale appears similarly timed: the stock is trading well below its 52-week high and has declined sharply over the past month, yet Bergmann's last sell did not precede that weakness. More concerning is the company's financial position: Capricor has zero annual revenue, a substantial net loss, and is burning cash while the stock remains above its 52-week low. The lack of any offsetting insider buying activity—despite the CFO's repeated selling—and the company's deteriorating fundamentals suggest Bergmann is reducing exposure rather than showing confidence in a near-term turnaround.